Ibiden Co.,Ltd.
IBIDF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $369 | $371 | $418 | $401 |
| % Growth | -0.3% | -11.3% | 4.1% | – |
| Cost of Goods Sold | $256 | $268 | $290 | $281 |
| Gross Profit | $113 | $102 | $128 | $120 |
| % Margin | 30.7% | 27.7% | 30.5% | 29.9% |
| R&D Expenses | $0 | $20 | $20 | $16 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $66 | $35 | $35 | $34 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $0 | $0 | $0 |
| Operating Expenses | $66 | $55 | $55 | $49 |
| Operating Income | $48 | $48 | $72 | $71 |
| % Margin | 12.9% | 12.8% | 17.3% | 17.7% |
| Other Income/Exp. Net | $4 | -$0 | -$1 | -$12 |
| Pre-Tax Income | $51 | $47 | $72 | $59 |
| Tax Expense | $17 | $16 | $19 | $18 |
| Net Income | $34 | $31 | $52 | $41 |
| % Margin | 9.1% | 8.5% | 12.5% | 10.3% |
| EPS | 241.32 | 225.44 | 373.73 | 295.34 |
| % Growth | 7% | -39.7% | 26.5% | – |
| EPS Diluted | 226.19 | 224.86 | 373.73 | 295.34 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $54 | $46 | $55 | $53 |
| EBITDA | $107 | $94 | $127 | $112 |
| % Margin | 28.9% | 25.4% | 30.5% | 28% |